Αρχειοθήκη ιστολογίου

Σάββατο 9 Δεκεμβρίου 2017

Controversies Regarding Use of Myeloid Growth Factors in Leukemia

This review focuses on the data supporting the use of myeloid growth factors (MGFs) in patients being treated for acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, and hairy cell leukemia, for which neutropenia is a common complication of treatment. However, due to the lack of randomized trial data or conflicting results of clinical studies, comprehensive guidelines have been difficult to formulate. Moreover, to date, these diagnoses have not been addressed in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for MGFs. However, in most cases, the general principles have been included in the applicable NCCN Guidelines for each individual cancer site.



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2jCG1Z0

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου